<DOC>
	<DOCNO>NCT02895750</DOCNO>
	<brief_summary>There limit data availability effect Metformin XR 24-h plasma glucose , available data chronic kidney disease ( CKD ) . The plan study aim provide data glucose plasma level relation metformin plasma level Diabetes Type II patient .</brief_summary>
	<brief_title>Efficacity Safety Metformin XR CKD Stage 1 3</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Type 2 diabetes patient age 18 80 year require metformin ( antidiabetic treatment ) Pregnancy lactation Hyperlactatemia ( &gt; 2.5 mmol/L ) No creatinine level available since 3 month Severe hepatic insufficiency No liver function parameter available Need investigation iodize contrast medium Hypersensitivity metformin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>diabetes type 2</keyword>
	<keyword>Metformin</keyword>
	<keyword>chronic kidney disease</keyword>
	<keyword>CKD</keyword>
</DOC>